Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001398432-17-000086
Filing Date
2017-05-17
Accepted
2017-05-17 17:11:28
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a13095.htm 10-Q 316181
2 EXHIBIT 31.1 exh31_1.htm EX-31.1 10048
3 EXHIBIT 32.1 exh32_1.htm EX-32.2 3203
  Complete submission text file 0001398432-17-000086.txt   4350907

Data Files

Seq Description Document Type Size
4 nphc-20170331.xml EX-101.INS 633764
5 nphc-20170331.xsd EX-101.SCH 72078
6 nphc-20170331_cal.xml EX-101.CAL 33547
7 nphc-20170331_def.xml EX-101.DEF 301708
8 nphc-20170331_lab.xml EX-101.LAB 382543
9 nphc-20170331_pre.xml EX-101.PRE 309038
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

EIN.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 17852547
SIC: 2833 Medicinal Chemicals & Botanical Products